Ritlecitinib in Alopecia Areata: A 24‐Week Real‐World Experience Contrasting <scp>JAK</scp> Inhibitor‐Naïve and <scp>JAK</scp> Inhibitor‐Experienced PatientsToshiki Okazaki, Yoshihide Asano, Moyuka Wada‐Irimada et al.|The Journal of Dermatology|2025Cited by 5